Viewing Study NCT01127451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-31 @ 12:09 PM
Study NCT ID: NCT01127451
Status: COMPLETED
Last Update Posted: 2022-04-13
First Post: 2010-05-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma
Sponsor: Eisai Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E7272-701
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View